Lee Jee, Goldberg Ira J
Department of Medicine, Columbia University, New York, NY 10032, USA.
Curr Hypertens Rep. 2007 Dec;9(6):462-6. doi: 10.1007/s11906-007-0085-4.
Under normal circumstances, most energy substrate used for heart contraction derives from fatty acids in the form of nonesterified fatty acids bound to albumin or fatty acids derived from lipolysis of lipoprotein-bound triglyceride by lipoprotein lipase (LpL). By creating LpL knockout mice (hLpL0), we learned that loss of cardiac LpL leads to myocardial dysfunction; therefore, neither nonesterified fatty acids nor increased glucose metabolism can replace LpL actions. hLpL0 mice do not survive abdominal aortic constriction and they develop more heart failure with hypertension. Conversely, we created a mouse overexpressing cardiomyocyte-anchored LpL. This transgene produced cardiac lipotoxicity and dilated cardiomyopathy. Methods to alter this phenotype and the causes of other models of lipotoxicity are currently being studied and will provide further insight into the physiology of lipid metabolism in the heart.
在正常情况下,用于心脏收缩的大多数能量底物来源于脂肪酸,其形式为与白蛋白结合的非酯化脂肪酸,或由脂蛋白脂肪酶(LpL)对脂蛋白结合的甘油三酯进行脂解产生的脂肪酸。通过创建LpL基因敲除小鼠(hLpL0),我们了解到心脏LpL的缺失会导致心肌功能障碍;因此,非酯化脂肪酸和增加的葡萄糖代谢都无法替代LpL的作用。hLpL0小鼠在腹主动脉缩窄后无法存活,并且会因高血压而出现更多心力衰竭。相反,我们创建了一种过表达心肌细胞锚定LpL的小鼠。这种转基因产生了心脏脂毒性和扩张型心肌病。目前正在研究改变这种表型的方法以及其他脂毒性模型的原因,这将为深入了解心脏脂质代谢的生理学提供更多信息。